Citation: Fh. Hochberg et G. Tabatabai, Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy, ANN HEMATOL, 80, 2001, pp. B111-B112
Authors:
Reni, M
Ferreri, AJM
Guha-Thakurta, N
Blay, JY
Dell'Oro, S
Biron, P
Hochberg, FH
Citation: M. Reni et al., Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate, INT J RAD O, 51(2), 2001, pp. 419-425
Authors:
Fitzek, MM
Thornton, AF
Harsh, G
Rabinov, JD
Munzenrider, JE
Lev, M
Ancukiewicz, M
Bussiere, M
Hedley-Whyte, ET
Hochberg, FH
Pardo, FS
Citation: Mm. Fitzek et al., Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: Results of an institutional phase I/II trial, INT J RAD O, 51(1), 2001, pp. 131-137
Authors:
Ichikawa, T
Petros, WP
Ludeman, SM
Fangmeier, J
Hochberg, FH
Colvin, OM
Chiocca, EA
Citation: T. Ichikawa et al., Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector, CANCER RES, 61(3), 2001, pp. 864-868
Citation: Hj. Aronen et al., High microvascular blood volume is associated with high glucose uptake andtumor angiogenesis in human gliomas, CLIN CANC R, 6(6), 2000, pp. 2189-2200
Authors:
Qureshi, NH
Bankiewicz, KS
Louis, DN
Hochberg, FH
Chiocca, EA
Harsh, GR
Citation: Nh. Qureshi et al., Multicolumn infusion of gene therapy cells into human brain tumors: Technical report, NEUROSURGER, 46(3), 2000, pp. 663-668
Citation: L. Kim et al., White-matter abnormalities in unirradiated patients cured of primary central nervous system lymphoma, NEURORADIOL, 42(6), 2000, pp. 406-412
Authors:
Harsh, GR
Deisboeck, TS
Louis, DN
Hilton, J
Colvin, M
Silver, JS
Qureshi, NH
Kracher, J
Finkelstein, D
Chiocca, EA
Hochberg, FH
Citation: Gr. Harsh et al., Thymidine kinase activation of ganciclovir in recurrent malignant gliomas:a gene-marking and neuropathological study, J NEUROSURG, 92(5), 2000, pp. 804-811
Authors:
Ikeda, K
Ichikawa, T
Wakimoto, H
Silver, JS
Deisboeck, TS
Finkelstein, D
Harsh, GR
Louis, DN
Bartus, RT
Hochberg, FH
Chiocca, EA
Citation: K. Ikeda et al., Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses, NAT MED, 5(8), 1999, pp. 881-887
Authors:
Guha-Thakurta, N
Damek, D
Pollack, C
Hochberg, FH
Citation: N. Guha-thakurta et al., Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients, J NEURO-ONC, 43(3), 1999, pp. 259-268
Authors:
Akpek, EK
Ahmed, I
Hochberg, FH
Soheilian, M
Dryja, TP
Jakobiec, FA
Foster, CS
Citation: Ek. Akpek et al., Intraocular-central nervous system lymphoma - Clinical features, diagnosis, and outcomes, OPHTHALMOL, 106(9), 1999, pp. 1805-1810
Authors:
Fitzek, MM
Thornton, AF
Rabinov, JD
Lev, MH
Pardo, FS
Munzenrider, JE
Okunieff, P
Bussiere, M
Braun, I
Hochberg, FH
Hedley-Whyte, ET
Liebsch, NJ
Harsh, GR
Citation: Mm. Fitzek et al., Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial, J NEUROSURG, 91(2), 1999, pp. 251-260
Authors:
Ostergaard, L
Hochberg, FH
Rabinov, JD
Sorensen, AG
Lev, M
Kim, L
Weisskoff, RM
Gonzalez, G
Gyldensted, C
Rosen, BR
Citation: L. Ostergaard et al., Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors, J NEUROSURG, 90(2), 1999, pp. 300-305